Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states

Table 7 Association between AIP and CAD severity in different glucose metabolic states

Glucose metabolic state	Multi-vessel coronary artery disease
	Model 1		Model 2		Model 3
	OR (95% CI)	P value	OR (95% CI)	P value	OR (95% CI)	P value
NGR
AIP	3.842 (1.032–14.302)	0.045	4.199 (1.045–16.881)	0.043	5.568 (1.099–28.200)	0.038
I	Reference		Reference		Reference
II	1.283 (0.539–3.056)	0.573	1.202 (0.480–3.009)	0.694	2.427 (0.835–7.052)	0.103
III	1.477 (0.620–3.521)	0.379	1.516 (0.603–3.811)	0.376	1.758 (0.570–5.416)	0.326
IV	2.045 (0.823–5.084)	0.123	2.093 (0.799–5.479)	0.133	3.524 (1.140–10.896)	0.029
P-trend	0.121		0.115		0.063
Pre-DM
AIP	1.513 (0.432–5.306)	0.518	1.565 (0.413–5.939)	0.510	0.950 (0.205–4.407)	0.948
I	Reference		Reference		Reference
II	0.931 (0.347–2.497)	0.887	0.936 (0.342–2.560)	0.897	0.812 (0.247–2.664)	0.731
III	1.470 (0.518–4.167)	0.469	1.413 (0.487–4.098)	0.524	1.235 (0.346–4.405)	0.745
IV	0.931 (0.347–2.497)	0.887	0.928 (0.332–2.597)	0.887	0.437 (0.121–1.584)	0.208
P-trend	0.972		0.955		0.237
DM
AIP	1.096 (0.331–3.633)	0.881	1.324 (0.346–5.060)	0.682	0.907 (0.177–4.650)	0.907
I	Reference		Reference		Reference
II	1.625 (0.543–4.865)	0.386	1.457 (0.469–4.522)	0.515	1.067 (0.250–4.548)	0.930
III	3.611 (1.092–11.944)	0.035	3.353 (0.951–11.816)	0.060	2.774 (0.548–14.029)	0.217
IV	0.843 (0.295–2.409)	0.749	0.928 (0.286–3.008)	0.901	0.550 (0.115–2.623)	0.453
P-trend	0.978		0.903		0.459

Model 1: unadjusted
Model 2: adjusted for age and sex
Model 3: adjusted for age, sex, SBP, BMI, smoking status, drinking status, LDL-C, hypertension, status of antihypertensive drugs, status of antidiabetic drugs, status of antilipidemic drugs, status of antiplatelet drugs
AIP atherogenic index of plasma, CAD coronary artery disease, SBP systolic blood pressure, BMI body mass index, LDL-C low-density lipoprotein cholesterol

ISSN: 1475-2840